CVE-2016-8355

moderate-risk

Published 2017-02-13

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Do I need to act?

0.39% chance of exploitation

EPSS score — low exploit probability

Not on CISA KEV list

No confirmed active exploitation reported to CISA

Patch status unknown

Check vendor advisories for fix availability and mitigation guidance

CVSS 9.9/10 Critical

NETWORK / LOW complexity

Affected Products (4)

Cadd-Solis Medication Safety Software

Affected Vendors

Smiths-Medical

References (4)

Third Party Advisory http://www.securityfocus.com/bid/94630

Third Party Advisory https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01

Third Party Advisory http://www.securityfocus.com/bid/94630

Third Party Advisory https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01

/ 100

moderate-risk

Severity 33/34 · Critical

Exploitability 1/34 · Minimal

Exposure 10/34 · Low